Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia

NCT05641142 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Hereditary Hemorrhagic Telangiectasia
Rendu Osler Disease

Interventions

OTHER: monitoring the use of anticoagulant and/or antiplatelet therapy in patients with osler rendering disease

Sponsor

University Hospital, Clermont-Ferrand